Esófago de Barrett como riesgo de adenocarcinoma esófagico: presentación de una serie de casos de 10 años en Hidalgo, México

Abstract

Barrett's esophagus is considered a major risk factor for esophageal adenocarcinoma, however, that risk has not been studied in the Mexican population.

Aims

To determine in a number of cases with Barrett‘s esophagus the incidence of esophageal adenocarcinoma after 10 years of endoscopical follow-up.

Material and methods

A retrospective, observational, longitudinal and descriptive study of 2673 upper GI endoscopy from the Hospital General de Zona y Medicina Familiar 1 of Instituto Mexicano del Seguro Social, between January 1, 2002 and December 31, 2012, of which we followed those that counted with endoscopically suspected of Barret's esophagus with histological confirmation. Finally, follow-up endoscopic studies were reviewed during 10 years to assess the incidence of adenocarcinoma.

Results

We reviewed a total of 36 patients (1.3%) confirmed with Barrett's esophagus, with an average follow-up of 5.4 years and a total of 196 years/patient. Over the course of 10 years, each patient received between 2 and 4 follow-up endoscopies, from which none reported adenocarcinoma.

Conclusion

The prevalence of Barrett's esophagus in this series was 1.3%, lower than that reported in the English literature. The incidence of adenocarcinoma in this 10 years’ series was null.